Case Report
Accepted on 20 Apr 2026
Upadacitinib for atopic dermatitis induced by secukinumab in patients with refractory ankylosing spondylitis:a case report
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Case Report
Accepted on 20 Apr 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 20 Apr 2026
in Plant Pathogen Interactions
Review
Accepted on 20 Apr 2026
in High-Energy and Astroparticle Physics
Case Report
Accepted on 20 Apr 2026
in Infectious Diseases: Pathogenesis and Therapy
Original Research
Accepted on 20 Apr 2026
in Higher Education
Original Research
Accepted on 20 Apr 2026
in Gastroenterology
Original Research
Accepted on 20 Apr 2026
in Interventions for Rehabilitation
Systematic Review
Accepted on 20 Apr 2026
in Family Medicine and Primary Care
Review
Accepted on 20 Apr 2026
in Geoscience and Society
Review
Accepted on 20 Apr 2026
in Neuropsychology
Original Research
Accepted on 20 Apr 2026
in Digital Impacts
Original Research
Accepted on 20 Apr 2026
in Planetary Health
Original Research
Accepted on 20 Apr 2026
in Animal Reproduction - Theriogenology
Original Research
Accepted on 20 Apr 2026
in Social Pediatrics
Review
Accepted on 20 Apr 2026
in Cancer Immunity and Immunotherapy
Brief Research Report
Accepted on 20 Apr 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders